Research on Alzheimer's disease, from early signs to new therapies. Covers screening tools, brain damage mechanisms, risk factors, sleep, and drug targets.
Scientists have identified a key molecular mechanism linking gene expression to synaptic plasticity in the aging human brain. The study reveals that age-related reductions in neurotransmitter receptor genes contribute to alterations in synaptic function, providing potential targets for Alzheimer's disease therapy.
Researchers at the University of Minnesota identified key neuropeptides involved in Alzheimer's, which may offer new avenues for early diagnosis and treatment. The study suggests that simulating neuropeptide activity could prevent cognitive decline.
A study published by the American Academy of Neurology found that people who follow the MIND and Mediterranean diets have fewer amyloid plaques and tau tangles, signs of Alzheimer's disease. The study, which involved 581 participants, suggests that these diets may be beneficial for brain health and cognition as people age.
People with recent atrial fibrillation diagnosis have a 13% higher risk of developing dementia. A stronger link is seen in younger patients and those without chronic kidney disease. The study's findings may lead to important clinical and public health implications.
Reducing mRNA methylation promotes migration of macrophages into the brain and clearance of toxic protein amyloid-beta. This pathway provides a potential new target for treatment of Alzheimer's disease.
A new study found significant links between sleep disturbances and the risk for developing dementia over a 10-year period. Sleep-maintenance insomnia was associated with a lower risk of dementia, while sleep-initiation insomnia and sleep medication use were linked to an increased risk.
The study found that oxidized membranes accelerate the aggregation of certain peptides associated with Alzheimer's disease, while others are prevented from aggregating. The research provides new insights into the mechanisms underlying peptide aggregation near lipid membranes.
Researchers have mapped changes to the retina that correspond to brain changes in Alzheimer's disease patients, opening a path to earlier diagnosis and more effective treatments. The study found accumulation of toxic proteins in retinas of patients with Alzheimer's disease and mild cognitive impairment, causing severe cell degeneration.
A new UC Davis study has identified 194 significantly different genes in the brains of people with autism, with many linked to brain connectivity, immune response, and inflammation. The research also found age-dependent differences in genes related to synaptic function and cell loss.
Researchers will use data from New IDEAS study to enroll a representative population of patients with memory impairment and their family members. The goal is to better understand the psychological impact of receiving biomarker-informed diagnoses and inform best practices in diagnostic evaluation.
Researchers at Massachusetts General Hospital developed an accurate method for detecting Alzheimer's disease using routinely collected clinical brain images. The AI model detected Alzheimer's disease risk with 90.2% accuracy across five datasets, regardless of age or scanner manufacturer.
Researchers at Chalmers University of Technology developed a method to predict fall accidents and cognitive illnesses like Alzheimer's disease using radar sensors that track walking patterns. The technology can help healthcare staff make more reliable risk assessments and tailor interventions for improved patient outcomes.
Researchers found that cholesterol increases the toxicity of a peptide implicated in Alzheimer's progression, altering its secondary structure and forming small, toxic clusters called oligomers. A diet rich in cholesterol may contribute to Alzheimer's disease development by changing the lipid composition of neuronal membranes.
Researchers have designed a compound that targets and breaks down phosphorylated p38, a posttranslationally modified protein closely associated with Alzheimer's disease. This breakthrough could provide a novel treatment for the disease and open up opportunities for future treatments of other 'undruggable' diseases.
A new screening tool developed by Cleveland Clinic researchers can effectively detect mild cognitive impairment, early Alzheimer's disease, and other related dementias in older adults. The tool has been shown to identify 90% of patients with mild cognitive impairment, offering a potential solution for early detection and prevention.
Researchers estimate transcription error rates in human cells and identify genetic and epigenetic factors responsible for inaccuracies. Inaccurate transcription produces truncated or altered proteins, leading to disease.
A research group at Uppsala University has developed an artificial blood-brain barrier model that can validate the effectiveness of antibodies in reaching the brain. The model allows for the testing of antibodies without the need for animal experimentation, providing a more efficient and cost-effective alternative.
The study found that nicotinamide riboside (NR) increases NAD+ levels in the blood, which is associated with lower biomarkers of neurodegenerative disease. Researchers measured NAD+ directly in extracellular vesicles and found a correlation between increased NAD+ and changes in disease biomarkers.
A new study has identified a biomarker, placental growth factor (PlGF), which is associated with cognitive impairment and dementia due to vascular brain injury. Higher levels of PlGF in the bloodstream are linked to increased risk of cognitive decline and cerebral small vessel disease.
Researchers found that gene therapy approach and small molecule treatment can calm the destructive cells of ALS by preserving upper motor neurons. Improving mitochondrial health also reduces astrocyte attack on diseased neurons, offering new hope for treating ALS.
Researchers found 270 distinct differentially methylated regions (DMRs) in AD brains compared to normal controls, validating their key findings using an independent cohort. The study offers a novel approach to investigating the relationship between DNA methylation and gene/protein expression.
Researchers found 21 Alzheimer's disease-related genes associated with obesity, including those linked to neuro-inflammation and amyloid-beta protein deposition. Obesity in midlife and women is more closely linked to dementia risk than late life or men.
The ENIGMA Initiative aims to bridge knowledge gaps on brain aging factors in developing countries, particularly in India. The study will collect comprehensive data on risk and protective factors through clinical interviews, bloodwork, and brain MRI to identify universal and population-specific predictors of dementia.
Researchers at Gladstone Institutes found that ApoE4 from neurons plays a critical role in Alzheimer's disease, contrary to previous focus on glial cells. The study shows that deleting ApoE4 from neurons reduces brain changes resembling Alzheimer's disease, offering new possibilities for treatment.
Scientists at Ben-Gurion University have discovered a groundbreaking treatment approach targeting the mitochondrial gatekeeper VDAC1 for Alzheimer's disease. The new therapy, VBIT-4, demonstrates significant improvement in mouse models, preventing cell death and neuroinflammation while promoting healthy neuron growth.
A new study suggests that even moderate amounts of alcohol can accelerate brain atrophy and increase amyloid plaques in Alzheimer's disease. Researchers found that chronic drinking altered healthy brain function and behavior, potentially setting the stage for increased plaque proliferation.
The Brain Canada Foundation and the Canadian Institutes of Health Research have invested $663,000 in two groundbreaking projects: REBALANCE and HiCALS. REBALANCE explores focused ultrasound as a potential treatment for Alzheimer's disease, while HiCALS investigates the link between high-fat diets and ALS survival.
Researchers found that platelet depletion increased amyloid plaque size and neuronal damage in APP-PS1 mice. However, platelets may have a beneficial role in limiting plaque growth and attenuating neuritic dystrophy at advanced stages of Alzheimer's disease.
Researchers create advanced imaging-based method for studying mitochondria, enabling detailed mapping and measurement of structural changes. This technique has potential applications in understanding diseases such as Alzheimer’s, Parkinson’s, and cancers where mitochondrial function is disrupted.
Researchers use movie clips to study mouse brain activity, revealing novel ways to diagnose learning and memory disorders. The discovery points to new ways to tackle Alzheimer's and improve artificial intelligence.
A University of Massachusetts Amherst epidemiologist is leading a team to better understand the effects of chronic stress on future health risks. They will examine metabolites in blood samples from a large, racially diverse population to identify potential biomarkers for heart disease, diabetes and cognitive decline.
A new analysis of 7,068 elderly Americans found that only 41% of cognitive decline can be statistically accounted for by dementia. Personal education, race, household wealth and income were the biggest contributors to population-level variation, but all factors accounted for only 5.6% of age-related change.
A novel nuclear medicine imaging protocol, dual-phase amyloid PET, can assess both amyloid deposition and neurodegeneration with a single tracer injection, cutting costs and radiation exposure. The protocol was shown to be comparable in distinguishing patients with neurodegenerative diseases from controls.
Researchers have identified a new protein in the cerebrospinal fluid that can reliably detect endothelial injury, a key contributor to cognitive impairment in pre-symptomatic stages of Alzheimer's. The discovery offers hope for improving diagnostic tests and potentially preventing damage to the brain endothelium.
The Alzheimer's Association redefines clinical meaningfulness, finding modest yet significant benefits from approved treatments that expand over time. Combination therapies are expected to provide more substantial benefits moving forward.
The work group reframed what is clinically meaningful to slow Alzheimer's disease progression, including the need for combination therapies and realistic expectations of benefits and risks. Slowing brain deterioration by four to six months in early stages may preserve function, leading to meaningful outcomes for patients and families.
Researchers at Bar-Ilan University have developed a new treatment for Alzheimer's disease that targets the earliest, pre-symptomatic signs of the disease. The treatment, using cyclic peptides, has shown promise in diagnosing and preventing progression of the disease by blocking the formation of toxic oligomers.
A UCF cancer researcher is studying the molecular causes of Alzheimer's disease by examining a protein deficiency in the brain. His research may lead to new targets for therapy and earlier diagnosis. The study focuses on KLF8, a protein important for brain function that has been recorded as deficient in patients with Alzheimer's.
A UTHealth Houston study found caregivers of people at high risk of CTE are more likely to seek information from social media than physicians. The study also showed that participants reported 77% of online CTE information is probably true, with league-sponsored websites and healthcare providers being the least credible sources.
A new study found that sleep medications increase the risk of dementia in white adults. However, the relationship between sleep medications and dementia risk varies by medication type and socio-economic status. The study suggests that patients with poor sleep should consider alternative solutions before taking medications.
A new study finds that obesity-related neurodegeneration mimics Alzheimer's disease, with grey matter atrophy patterns similar in both groups. The researchers suggest that controlling excess weight could lead to improved health outcomes and slowed cognitive decline.
Researchers at Washington University in St. Louis have developed a non-invasive method called sonobiopsy that uses focused ultrasound to release neurodegenerative biomarkers into the blood, facilitating diagnosis of conditions like Alzheimer’s disease. The technique has shown promising results in releasing tau proteins and another biom...
An international task force led by UNIGE and HUG has developed a preventive protocol to address the growing number of people affected by Alzheimer's disease. The guidelines focus on four pillars: risk assessment, risk communication, risk reduction, and cognitive enhancement.
Research found that experiencing three or more concussions is linked with worsened brain function in later life. Participants who reported multiple concussions showed significant cognitive decline, particularly in attention and complex task completion.
A new study found that online forums provide a sense of community and hope for people with dementia, filling an important gap in their support after diagnosis. The forums allow users to share experiences and receive emotional support from others going through similar experiences, helping to alleviate feelings of isolation.
Researchers from the University of Tsukuba have found distinct changes in brain activity patterns that can differentiate between Alzheimer's disease and Lewy body dementia. These changes were present before symptoms emerged and could be detected using conventional MRI.
Researchers developed a blood-based test that predicts Alzheimer's disease risk by analyzing changes in brain cell growth and division. The study found that the body's circulatory system can modulate the formation of new brain cells, and that this process occurs 3.5 years before a clinical diagnosis.
A new study led by the University of California San Diego found that daily walking and moderate-to-vigorous physical activity significantly reduced the risk of developing mild cognitive impairment or dementia in senior women. With each additional 1,865 steps per day, the risk was lowered by 33%, while moderate-to-vigorous physical acti...
A decade-long study found that a healthy lifestyle, including a healthy diet, regular exercise, and cognitive activity, slows memory decline in older adults. Participants with the APOE gene, associated with Alzheimer's disease, also experienced slower memory loss.
Researchers identified an alternative binding site on amyloid-beta aggregates using time-resolved spectroscopy and computational chemistry. This discovery could lead to the development of new therapies for Alzheimer's disease and other conditions associated with amyloid deposits.
Researchers at UW-Madison developed silica nanocapsules that can carry CRISPR tools across the blood-brain barrier, enabling brain-wide gene editing for disorders like Alzheimer's and Parkinson's. The technology has potential for non-invasive delivery of gene therapies.
Researchers at Beckman Institute for Advanced Science and Technology will use a unique combination of MRI and mass spectrometry imaging techniques to study Alzheimer's disease on an unprecedented scale. By capturing detailed chemical information, they aim to understand the molecular-level changes that occur in aging brains and develop ...
The team's sensor detects Tumour Necrosis Factor alpha (TNF alpha), a biomarker involved in inflammation, which is linked to various diseases including Alzheimer's. The biosensor is sensitive and can detect low concentrations of TNF alpha, making it a promising tool for early disease detection.
Swansea University scientists developed a smart patch that can detect proinflammatory biomarkers of neurodegenerative diseases, including Alzheimer's, using microneedle technology. The patches can be self-administered for point-of-care diagnosis and have the potential to change the landscape of early disease detection.
A new study finds that dietary choline deficiency can cause profound negative effects on the body, including organ damage and changes in brain pathology associated with Alzheimer's disease. The research highlights the importance of adequate choline intake to protect against neurodegeneration and improve overall health.
Researchers found that mice exposed to WTCPM dust exhibit impaired spatial recognition and memory, as well as changes in genes related to immune-inflammatory responses. The study suggests a peripheral-brain immune inflammatory 'cross-talking' mechanism that may increase cognitive decline risk.
Researchers developed HippoCamera, a new smartphone app that significantly improves memory recall by boosting attention to daily events. Users record videos and audio descriptions of everyday experiences, which are then replayed to reinforce memory consolidation.
Researchers have developed a novel blood-based biomarker, brain-derived tau (BD-tau), that specifically measures non-phosphorylated tau originating from the brain. This breakthrough addresses an unmet need for a blood test that tracks neurodegenerative changes in Alzheimer's disease but not in other dementias.
A new study suggests that hormone replacement therapy (HRT) could help prevent Alzheimer's disease in women who are carriers of the APOE4 gene. The research found that HRT use is associated with improved memory and larger brain volumes among at-risk women. Early introduction of HRT during perimenopause may be particularly beneficial.
Research exploring cannabis and its impact on the oral microbiome found a link between frequent cannabis use and increased levels of bacteria Actinomyces meyeri in the mouth. The study suggests that this bacterial imbalance may contribute to neurological disease, such as Alzheimer's disease, and memory loss.